4.2 Review

A Short Review on the Current Understanding of Autism Spectrum Disorders

Journal

EXPERIMENTAL NEUROBIOLOGY
Volume 25, Issue 1, Pages 1-13

Publisher

KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE
DOI: 10.5607/en.2016.25.1.1

Keywords

Autistic Disorders; Review; Neurobiology; Amygdala

Funding

  1. Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311011-05-3-SB020]
  2. Korea Healthcare Technology RD Project [HI11C21100200]
  3. Ministry of Health & Welfare, Republic of Korea
  4. Technology Innovation Program [10050154]
  5. Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information
  6. Ministry of Trade, Industry & Energy (MI, Korea)
  7. Bio & Medical Technology Development Program of the NRF-Korean government, MSIP [2015M3C7A1028926]

Ask authors/readers for more resources

Autism spectrum disorder (ASD) is a set of neurodevelopmental disorders characterized by a deficit in social behaviors and nonverbal interactions such as reduced eye contact, facial expression, and body gestures in the first 3 years of life. It is not a single disorder, and it is broadly considered to be a multi-factorial disorder resulting from genetic and non-genetic risk factors and their interaction. Genetic studies of ASD have identified mutations that interfere with typical neurodevelopment in utero through childhood. These complexes of genes have been involved in synaptogenesis and axon motility. Recent developments in neuroimaging studies have provided many important insights into the pathological changes that occur in the brain of patients with ASD in vivo. Especially, the role of amygdala, a major component of the limbic system and the affective loop of the cortico-striatothalamo- cortical circuit, in cognition and ASD has been proved in numerous neuropathological and neuroimaging studies. Besides the amygdala, the nucleus accumbens is also considered as the key structure which is related with the social reward response in ASD. Although educational and behavioral treatments have been the mainstay of the management of ASD, pharmacological and interventional treatments have also shown some benefit in subjects with ASD. Also, there have been reports about few patients who experienced improvement after deep brain stimulation, one of the interventional treatments. The key architecture of ASD development which could be a target for treatment is still an uncharted territory. Further work is needed to broaden the horizons on the understanding of ASD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available